New research shows that a weight loss plateau on GLP-1s isn’t treatment failure — it's biology
If you've heard of GLP-1 medications, like semaglutide or tirzepatide*, you've likely heard stories of dramatic weight loss. These medications have transformed obesity treatment by helping many people lose significant amounts of weight.
But there's another part of the story that isn't discussed as often: eventually, weight loss slows — or even stops.
